Methods for producing biphasic insulin formulations

Details Methods for producing biphasic insulin formulations Methods for producing biphasic insulin formulations

1998-11-24

2000-10-03

Lee, Howard C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 4, 514 53, 514 61, 514866, A61K 3828, A61K 3170, A61K 31715

Patent

active

061273341

ABSTRACT:
Insulin preparations of superior physical stability, comprising dissolved and/or precipitated human insulin or an analogue or derivative thereof, and a water-soluble reduced or non-reducing carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or a water-soluble non-reducing ester and/or ether derivative of a carbohydrate or reduced carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or mixtures thereof are disclosed.

REFERENCES:
patent: 4439181 (1984-03-01), Blackshear et al.
patent: 4839341 (1989-06-01), Massey et al.
patent: 4876241 (1989-10-01), Feldman et al.
patent: 5053389 (1991-10-01), Balschmidt et al.
patent: 5149777 (1992-09-01), Hansen et al.
patent: 5164366 (1992-11-01), Balschmidt et al.
patent: 5430016 (1995-07-01), Balschmidt et al.
patent: 5514646 (1996-05-01), Chance et al.
patent: 5552385 (1996-09-01), Christensen et al.
patent: 5631347 (1997-05-01), Baker et al.
patent: 5693609 (1997-12-01), Baker et al.
patent: 5705482 (1998-01-01), Christensen et al.
Pharmaceutical Dosage Forms and Drug Delivery Systems, edited by Ansel et al., publ. by Williams and Wilkins, pp. 317-322, Jan. 1995.
Brange et al., "Chemical Stability of Insulin. 1. Hydrolytic Degradation During Storage of Pharmaceutical Preparations", Pharmaceutical Research, vol. 9(6): 715-726, (1992).
Brange et al., "Chemical Stability of Insulin. 2. Formation of Higher Molecular Weight Transformation Products During Storage of Pharmaceutical Preparations", Pharmaceutical Research, vol. 9(6): 727-734, (1992).
Brange et al., "Chemical Stability of Insulin. 3. Influence of excipients, formulation, and pH", Acta. Pharm. Nord., vol. 4(3): 149-158, (1992).
Kim et al., "Precipitation of Insulintropin in the Presence of Protamine: Effect of Phenol and Zinc on the Isophane Ratio and the Insulinotropin Concentration in the Supernatant", Pharmaceutical Research, vol. 12(9): 1284-1288, (1995).
Gupta and Bhat "Effect of solvent additives on the thermal stability of insulin" (Center for Biotechnology, New Delhi pp. 209-212.

Affiliated with

Also associated with

Rating

Methods for producing biphasic insulin formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for producing biphasic insulin formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for producing biphasic insulin formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-195480